OXCARBAZEPINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy. (Chemical Entities of Biological Interest Ontology, CHEBI_7824)
External Link https://dgidb.org/results?searchType=drug&searchTerms=OXCARBAZEPINE
Similar Terms
Downloads & Tools

Genes

18 interacting proteins for the OXCARBAZEPINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
UGT1A8 UDP glucuronosyltransferase 1 family, polypeptide A8 0.309544
UGT1A7 UDP glucuronosyltransferase 1 family, polypeptide A7 0.294067
UGT1A10 UDP glucuronosyltransferase 1 family, polypeptide A10 0.267333
UGT1A9 UDP glucuronosyltransferase 1 family, polypeptide A9 0.226205
SCN11A sodium channel, voltage gated, type XI alpha subunit 0.0891111
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 0.0852367
SCN5A sodium channel, voltage gated, type V alpha subunit 0.0832264
HLA-B major histocompatibility complex, class I, B 0.0600136
SCN7A sodium channel, voltage gated, type VII alpha subunit 0.0498418
SCN3A sodium channel, voltage gated, type III alpha subunit 0.0402831
SCN2A sodium channel, voltage gated, type II alpha subunit 0.038693
SCN4A sodium channel, voltage gated, type IV alpha subunit 0.038693
SCN8A sodium channel, voltage gated, type VIII alpha subunit 0.0381905
SCN1A sodium channel, voltage gated, type I alpha subunit 0.0377008
SCN10A sodium channel, voltage gated, type X alpha subunit 0.032315
SCN9A sodium channel, voltage gated, type IX alpha subunit 0.0309544
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 0.0281403
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor 0.00602596